Advanced Medical Solutions Group plc
(“AMS” or the “Group”)
Exercise of share options and Directors’ dealings
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global medical technology company, today announces that following the successful achievement of certain performance criteria and the release of the recent preliminary results statement, the following options from certain share incentive schemes have been exercised as outlined below,
In order to cover the exercise cost and the tax payable on this exercise the directors have sold ordinary shares of 5p each on 22 March 2010 as detailed below.
Long Term Incentive Plan (LTIP)
|
Director |
No. of LTIPs prior to exercise |
LTIPs exercised |
LTIPs after exercise |
|
Don Evans CEO |
3,295,016 |
3,001,173 |
293,843 |
|
Chris Meredith COO |
1,797,234 |
1,208,000 |
589,234 |
|
Mary Tavener FD |
2,407,979 |
2,214,571 |
193,408 |
Deferred Share Bonus Plan (DSB)
|
Director
|
No. of DSBs prior to exercise |
DSBs exercised |
DSBs after exercise |
|
Don Evans CEO |
218,997 |
90,410 |
128,587 |
|
Chris Meredith COO |
135,130 |
49,313 |
85,827 |
|
Mary Tavener FD |
194,147 |
90,410 |
103,737 |
Unapproved Executive Share Option Scheme
|
Director |
No. of options prior to exercise |
Options exercised |
Options after exercise |
|
Don Evans CEO |
616,666 |
616,666 |
0 |
|
Mary Tavener FD |
300,000 |
300,000 |
0 |
Directors’ Dealings in shares
|
Director
|
Holding prior to exercise |
Holding following exercise |
Number of shares sold |
Sale price (p) |
Resultant holding |
% of issued share capital |
|
Don Evans CEO |
869,591 |
4,577,840 |
1,394,125 |
35.00 |
3,183,715 |
2.1 |
|
Chris Meredith COO |
74,538 |
1,331,851 |
229,962 |
35.00 |
1,101,889 |
0.7 |
|
Mary Tavener FD |
246,130 |
2,851,111 |
782,070 |
35.00 |
2,069,041 |
1.3 |
For further information, please contact:
|
Advanced Medical Solutions Group plc |
|
|
Don Evans, Chief Executive Officer Mary Tavener, Finance Director Chris Meredith, Chief Operating Officer |
Tel: +44 (0) 1606 545508 |
|
|
|
|
Tavistock Communications |
Tel: +44 (0) 20 7920 3150 |
|
John West / Chris Munden |
|
|
|
|
|
Investec Bank plc |
Tel: +44 (0) 20 7597 5970 |
|
Gary Clarence / Daniel Adams |
|
Notes to Editors:
Advanced Medical Solutions develops and manufactures products for the $15 billion global woundcare market.
Founded in 1991 and quoted on AIM, Advanced Medical Solutions is focused on the design, development and manufacture of innovative products for advanced woundcare and wound closure.
The advanced woundcare products are based on the moist wound healing principle. AMS uses its in-house technology to provide a vertically integrated ‘one stop shop’ for all categories of moist wound healing products. The Company has the capability to move a product from design and development through to production and delivery for distribution and sale into customer markets.
AMS’ technology in cyanoacrylate based tissue adhesives is used for the closure of small cuts and trauma wounds through to large surgical incisions, and also for protecting or sealing skin to prevent breakdown or infection.
AMS’ products which currently serve the majority of the key global markets are sold either direct or through strategic partners and distributors.
This information is provided by RNS
END
RDSBDGDXGBDBGGX